Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin
- PMID: 911167
Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin
Abstract
Two patients had acute phototoxic reactions after intravenous injections of hematoporphyrin (7 mg/kg) and exposure to light. These reactions were characterized by pain, redness, and swelling of affected sites. Controlled clinical studies were instituted using known types and amounts of light to ascertain the degree of photosensitivity at various time intervals after drug administration. In addition, action spectrum studies elicited a peak response at 405 nm (+/- 5 nm). Plasma hematoporphyrin concentration was approximately 520 microgram/100 ml one hour after hematoporphyrin infusion and it gradually declined during a period of 42 days with a biphasic diminution that suggested the existence of at least two pools of hematoporphyrin with half-life decay times of 16 hours and 12 days. beta-carotene was administered to ascertain whether or not the phototoxic response could be modified. It is suggested that a degree of protection was obtained that was insufficient to protect the patient.
Similar articles
-
[Photosensitization after intramuscular injections of hematoporphyrin. 3 cases].Ann Dermatol Venereol. 1987;114(4):543-9. Ann Dermatol Venereol. 1987. PMID: 3619300 French.
-
[Photosensitization complications after intramuscular injection of hematoporphyrin. Apropos of 23 cases].Ann Dermatol Venereol. 1981;108(1):95-101. Ann Dermatol Venereol. 1981. PMID: 7235508 French. No abstract available.
-
[Risk of incompatibility between intramuscular hematoporphyrin and whole-body tanning].Nouv Presse Med. 1980 Apr 19;9(18):1305-6. Nouv Presse Med. 1980. PMID: 7375365 French. No abstract available.
-
Therapeutic advances: combining photoradiation and laser therapy.Compr Ther. 1990 Apr;16(4):3-8. Compr Ther. 1990. PMID: 2139838 Review. No abstract available.
-
Drug-induced photosensitivity.Clin Pharm. 1993 Aug;12(8):580-7. Clin Pharm. 1993. PMID: 8222522 Review.
Cited by
-
Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.Br J Cancer. 1990 Mar;61(3):407-11. doi: 10.1038/bjc.1990.89. Br J Cancer. 1990. PMID: 2328207 Free PMC article.
-
Hypericin-photodynamic therapy induces human umbilical vein endothelial cell apoptosis.Sci Rep. 2015 Dec 17;5:18398. doi: 10.1038/srep18398. Sci Rep. 2015. PMID: 26673286 Free PMC article.
-
Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model.Br J Cancer. 1992 Jun;65(6):818-24. doi: 10.1038/bjc.1992.175. Br J Cancer. 1992. PMID: 1616853 Free PMC article.
-
Photodynamic cell killing effects and acute skin photosensitivity of aluminum-chloro-tetrasulfonated phthalocyanine and hematoporphyrin derivative.Jpn J Cancer Res. 1991 May;82(5):599-606. doi: 10.1111/j.1349-7006.1991.tb01892.x. Jpn J Cancer Res. 1991. PMID: 1905706 Free PMC article.
-
Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine.Br J Cancer. 1996 Dec;74(12):1891-9. doi: 10.1038/bjc.1996.650. Br J Cancer. 1996. PMID: 8980387 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources